Patent Assignment
Reel/Frame 042246/0375
Change of Name
Recorded: 2017-05-04
Pages: 2
Assignor
QLT INC.
Executed: 2016-11-29
Assignee
NOVELION THERAPEUTICS INC.
887 GREAT NORTHERN WAY, SUITE 101, VANCOUVER, B.C., V5T 4T5, CANADA
Covered Property
(1)
Therapeutic Regimen and Methods for Treating or Ameliorating Visual Disorders Associated with an Endogenous Retinoid Deficiency
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 2011
From: STRONG, H ANDREW; CADDEN, SUZANNE
To: QLT INC.
Reel/Frame 026547/0599 →
Assignment of Assignor's Interest
Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
Assignment of Assignor's Interest
Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
Assignment of Assignor's Interest
Apr 7, 2021
From: RETINAGENIX THERAPEUTICS, INC.
To: RETINAGENIX HOLDINGS LLC
Reel/Frame 055857/0001 →
Assignment of Assignor's Interest
Aug 9, 2022
From: RETINAGENIX HOLDINGS LLC
To: ELUMINEX BIOSCIENCES (SUZHOU) LIMITED
Reel/Frame 060763/0001 →